We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
-12.47%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.72B
AUM Growth
-$237M
Cap. Flow
+$240M
Cap. Flow %
13.91%
Top 10 Hldgs %
74.83%
Holding
51
New
2
Increased
2
Reduced
5
Closed

Top Buys

Rank Stock Value
1
PRME icon
Prime Medicine
PRME
+$240M
2
CRWD icon
CrowdStrike
CRWD
+$85.2M
3
GTLB icon
GitLab
GTLB
+$31.7M
4
EQRX
EQRx, Inc. Common Stock
EQRX
+$484K

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$82.3M
2
VLD
Velo3D, Inc.
VLD
+$12M
3
VERV
Verve Therapeutics
VERV
+$11.3M
4
LYFT icon
Lyft
LYFT
+$10.6M
5
RANI icon
Rani Therapeutics
RANI
+$1.49M

Sector Composition

Rank Sector Weight
1 Healthcare 54.09%
2 Technology 31.93%
3 Industrials 9%
4 Financials 2.36%
5 Consumer Staples 2.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRME icon
1
Prime Medicine
PRME
$533M
$247M 14.34%
+13,284,688
New +$240M
VERV
2
DELISTED
Verve Therapeutics
VERV
$204M 11.86%
10,549,086
-424,925
-4% -$11.3M
PATH icon
3
UiPath
PATH
$5.62B
$179M 10.39%
14,068,674
DXCM icon
4
DexCom
DXCM
$27.6B
$142M 8.22%
1,250,000
-750,000
-38% -$82.3M
PL icon
5
Planet Labs
PL
$7.3B
$139M 8.07%
31,942,641
EQRX
6
DELISTED
EQRx, Inc. Common Stock
EQRX
$117M 6.81%
47,675,476
+122,789
+0.3% +$484K
SNOW icon
7
Snowflake
SNOW
$92.9B
$76.9M 4.47%
535,604
CRWD icon
8
CrowdStrike
CRWD
$187B
$65.5M 3.8%
+2,488,292
New +$85.2M
FRSH icon
9
Freshworks
FRSH
$2.84B
$59.4M 3.45%
4,035,595
OSCR icon
10
Oscar Health
OSCR
$8.5B
$59.1M 3.44%
24,042,864
GTLB icon
11
GitLab
GTLB
$5.28B
$58.8M 3.42%
1,294,527
+701,123
+118% +$31.7M
LYFT icon
12
Lyft
LYFT
$5.39B
$57.9M 3.37%
5,257,563
-880,591
-14% -$10.6M
DUOL icon
13
Duolingo
DUOL
$5.7B
$50.1M 2.91%
704,444
HOOD icon
14
Robinhood
HOOD
$85.2B
$40.1M 2.33%
4,928,535
BHIL
15
DELISTED
Benson Hill, Inc.
BHIL
$39.7M 2.3%
438,636
RLAY icon
16
Relay Therapeutics
RLAY
$4.02B
$23.4M 1.36%
1,568,753
LYEL icon
17
Lyell Immunopharma
LYEL
$309M
$20.4M 1.18%
293,256
DM
18
DELISTED
Desktop Metal, Inc.
DM
$15M 0.87%
1,104,873
ME
19
DELISTED
23andMe Holding Co
ME
$14.6M 0.85%
336,839
BEAM icon
20
Beam Therapeutics
BEAM
$2.58B
$12.6M 0.73%
321,604
GLUE icon
21
Monte Rosa Therapeutics
GLUE
$1.92B
$11.1M 0.65%
1,464,015
SANA icon
22
Sana Biotechnology
SANA
$885M
$11.1M 0.65%
2,812,500
ILMN icon
23
Illumina
ILMN
$29.4B
$10.8M 0.63%
54,967
RAPT
24
DELISTED
RAPT Therapeutics
RAPT
$10.7M 0.62%
67,534
IVVD icon
25
Invivyd
IVVD
$180M
$8.52M 0.49%
5,680,785

Similar funds

Alphabet Inc's Q4 2022 Portfolio in Review

As of Q4 2022, Alphabet Inc held 51 positions worth $1.72B, down 12% from $1.96B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Alphabet Inc deployed $240M of net new capital in Q4 2022, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Prime Medicine: 13,284,688 shares worth $247M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 58% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was DexCom, an estimated $82.3M trimmed.

  • Alphabet Inc's largest Q4 2022 buy was Prime Medicine: 13,284,688 shares worth $247M.
  • Alphabet Inc added most to GitLab in Q4 2022, an estimated $31.7M increase.
  • Alphabet Inc's biggest Q4 2022 reduction was DexCom, cutting an estimated $82.3M.
  • Alphabet Inc's ten largest holdings make up 75% of its $1.72B portfolio in Q4 2022.
  • Alphabet Inc opened 2 new positions and closed 0 in Q4 2022.
  • Alphabet Inc's portfolio value fell 12% quarter-over-quarter to $1.72B.

Based on Alphabet Inc's 13F filing for Q4 2022, filed 14 Feb 2023.